Elekta announces changes to its Executive Management team
STOCKHOLM, May 8, 2014 – Elekta announced today that it has appointed Åsa Hedin as Executive Vice President (EVP) Corporate Strategy, assuming responsibility for Strategy, Marketing and Education & Training. Elekta also announced that Maurits Wolleswinkel has been appointed as EVP Neuroscience from August 1, 2014.
Åsa Hedin will continue to report to Elekta’s new CEO, Niklas Savander, as a member of the Executive Management team. She has led Elekta Neuroscience since 2007. Earlier in her career, Åsa held executive positions at Siemens Healthcare and Gambro AB.
Maurits Wolleswinkel will become a new member of the Executive Management team. Maurits joined Elekta Brachytherapy in 2011 from Philips Healthcare and is currently responsible for Brachytherapy Business Line Management.
Elekta President and CEO, Niklas Savander, says: “I am very happy with both appointments. Åsa’s experience and skills make her well suited for this new critical role in the company. The functions under her leadership form a critical platform for Elekta’s future success. Maurits is a talented leader whose broad cross-functional experience is ideal for our Neuroscience business. He will focus on continuing the growth of this patient-centric business together with our dedicated customers.”
# # #
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on May 8, 2014.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.
Tags:
